Aspira Pathlab & Diagnostics Ltd.BSE: ASPIRA

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Oct 1, 2026 at 12:56 AM EDT · Issued by Aspira Pathlab & Diagnostics Ltd. via BSE India

Filed with BSE · Oct 1, 2026 at 12:56 AM EDT · 3 pages · English

On 6ix: 6ix.com/news/disclosures-under-reg-292-of-sebi-sast-regulations-2011

Aspira Pathlab & Diagnostics Ltd. on 6ix

Earlier from Aspira Pathlab & Diagnostics

Later from Aspira Pathlab & Diagnostics

Board Meeting Intimation for Board Meeting To Be Held On November 06, 2026 For The Second Quarter/Half Year Ended September 30, 2026Oct 31
Board Meeting Outcome for Outcome Of Board Meeting Dated 6Th November 2026Nov 6
Financial Result For Half Year Ended 30Th September 2026Nov 6
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 7

All Aspira Pathlab & Diagnostics news releases

Follow Aspira Pathlab & Diagnostics into a list and get an email when it puts out news.

Follow Aspira Pathlab & Diagnostics